Company Filing History:
8 out of 261 
4 out of 1,279 
Years Active: 2004-2016
Title: Innovations by Philip Michael Potter: Advancing Chemotherapy and Drug Metabolism
Introduction
Philip Michael Potter, a prominent inventor based in Memphis, TN, is renowned for his contributions to the fields of cancer treatment and drug metabolism. With a remarkable portfolio of eight patents, Potter's work focuses on innovative compositions and methods for enhancing the efficacy of prodrugs and sensitizing tumor cells to chemotherapy.
Latest Patents
Potter's latest patents illustrate his groundbreaking research. Among them is a patent titled "Composition and Method for Inhibiting Tumor Cell Growth," which introduces polynucleotides encoding a secreted mutant human carboxylesterase enzyme. This enzyme is designed to metabolize prodrugs into active drugs, potentially revolutionizing cancer treatment by providing methods for sensitizing cells to prodrug agents and facilitating the metabolism of organophosphates. Another significant patent is "Method for Sensitizing Tumor Cells to Chemotherapeutic Prodrug CPT-11," which similarly utilizes polynucleotides for the same purposes of inhibiting cell growth and treatment of drug addiction, complemented by a screening assay for identifying drugs activated by this enzyme.
Career Highlights
Throughout his career, Philip Michael Potter has worked with notable institutions such as St. Jude Children's Research Hospital and the University of North Carolina at Chapel Hill. His role in these organizations has allowed him to collaborate with leading experts and contribute significantly to scientific advancements in his field.
Collaborations
Potter has had the opportunity to work alongside talented individuals, including Monika Weirdl and Matthew Robert Redinbo. These collaborations have likely fostered innovative ideas and propelled the research forward, highlighting the importance of teamwork in scientific exploration.
Conclusion
Philip Michael Potter's innovative patents and research efforts exemplify the critical intersection of invention and healthcare. His work is paving the way for more effective treatments for cancer patients and expanding our understanding of drug metabolism, ultimately having a lasting impact on the medical field.